U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS
This repository is under review for potential modification in compliance with Administration directives.

Approval Year

1996
224
Name Type Language
RETEVASE
Preferred Name English
RETEPLASE
EMA EPAR   INN   MART.   MI   USAN   VANDF   WHO-DD  
INN   USAN  
Official Name English
RETEPLASE, RECOMBINANT
Common Name English
ECOKINASE
Brand Name English
HUMAN T-PA AMINO ACIDS 1-3 AND 176-527)
Common Name English
reteplase [INN]
Common Name English
HUMAN TISSUE-TYPE PLASMINOGEN ACTIVATOR(AMINO ACIDS 1-3 AND 176-527)
Common Name English
RETEPLASE [PURPLE BOOK CDER]
Common Name English
BM-06.022
Code English
RETEPLASE [VANDF]
Common Name English
BM-06022
Code English
RETEPLASE [USAN]
Common Name English
RETAVASE
Brand Name English
RAPILYSIN
Brand Name English
BM 06.022
Code English
RETEPLASE,RECOMBINANT [VANDF]
Common Name English
RETEPLASE [MI]
Common Name English
HUMAN T-PA (RESIDUES 1-3 AND 176-527)
Common Name English
Reteplase [WHO-DD]
Common Name English
RETEPLASE [EMA EPAR]
Common Name English
RETEPLASE [MART.]
Common Name English
Classification Tree Code System Code
WHO-ATC B01AD07
Created by admin on Tue Apr 01 22:41:28 GMT 2025 , Edited by admin on Tue Apr 01 22:41:28 GMT 2025
NCI_THESAURUS C29750
Created by admin on Tue Apr 01 22:41:28 GMT 2025 , Edited by admin on Tue Apr 01 22:41:28 GMT 2025
EMA ASSESSMENT REPORTS ECOKINASE (WITHDRAWN: MYOCARDIAL INFARCTION)
Created by admin on Tue Apr 01 22:41:28 GMT 2025 , Edited by admin on Tue Apr 01 22:41:28 GMT 2025
WHO-VATC QB01AD07
Created by admin on Tue Apr 01 22:41:28 GMT 2025 , Edited by admin on Tue Apr 01 22:41:28 GMT 2025
EMA ASSESSMENT REPORTS RAPILYSIN (AUTHORIZED: MYOCARDIAL INFARCTION)
Created by admin on Tue Apr 01 22:41:28 GMT 2025 , Edited by admin on Tue Apr 01 22:41:28 GMT 2025
Code System Code Type Description
EVMPD
SUB10290MIG
Created by admin on Tue Apr 01 22:41:28 GMT 2025 , Edited by admin on Tue Apr 01 22:41:28 GMT 2025
PRIMARY
INN
7102
Created by admin on Tue Apr 01 22:41:28 GMT 2025 , Edited by admin on Tue Apr 01 22:41:28 GMT 2025
PRIMARY
FDA UNII
DQA630RIE9
Created by admin on Tue Apr 01 22:41:28 GMT 2025 , Edited by admin on Tue Apr 01 22:41:28 GMT 2025
PRIMARY
SMS_ID
100000089183
Created by admin on Tue Apr 01 22:41:28 GMT 2025 , Edited by admin on Tue Apr 01 22:41:28 GMT 2025
PRIMARY
RXCUI
76895
Created by admin on Tue Apr 01 22:41:28 GMT 2025 , Edited by admin on Tue Apr 01 22:41:28 GMT 2025
PRIMARY RxNorm
DAILYMED
DQA630RIE9
Created by admin on Tue Apr 01 22:41:28 GMT 2025 , Edited by admin on Tue Apr 01 22:41:28 GMT 2025
PRIMARY
MESH
C087896
Created by admin on Tue Apr 01 22:41:28 GMT 2025 , Edited by admin on Tue Apr 01 22:41:28 GMT 2025
PRIMARY
DRUG CENTRAL
5044
Created by admin on Tue Apr 01 22:41:28 GMT 2025 , Edited by admin on Tue Apr 01 22:41:28 GMT 2025
PRIMARY
CAS
133652-38-7
Created by admin on Tue Apr 01 22:41:28 GMT 2025 , Edited by admin on Tue Apr 01 22:41:28 GMT 2025
PRIMARY
MERCK INDEX
m9554
Created by admin on Tue Apr 01 22:41:28 GMT 2025 , Edited by admin on Tue Apr 01 22:41:28 GMT 2025
PRIMARY Merck Index
ChEMBL
CHEMBL2107885
Created by admin on Tue Apr 01 22:41:28 GMT 2025 , Edited by admin on Tue Apr 01 22:41:28 GMT 2025
PRIMARY
WIKIPEDIA
RETEPLASE
Created by admin on Tue Apr 01 22:41:28 GMT 2025 , Edited by admin on Tue Apr 01 22:41:28 GMT 2025
PRIMARY
NCI_THESAURUS
C90972
Created by admin on Tue Apr 01 22:41:28 GMT 2025 , Edited by admin on Tue Apr 01 22:41:28 GMT 2025
PRIMARY
DRUG BANK
DB00015
Created by admin on Tue Apr 01 22:41:28 GMT 2025 , Edited by admin on Tue Apr 01 22:41:28 GMT 2025
PRIMARY
ACTIVE MOIETY
RETEPLASE
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966